New Delhi: AIIMS Delhi will start human trials of Covaxin — country’s first indigenous COVID-19 vaccine — next week with 100 healthy volunteers in the age group of 18-55 years.
For a period of 150 days the volunteers will be kept under observation. The vaccine has been developed by Bharat Biotech collaborating with Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV).
“We will begin human trials of India’s first indigenous vaccine, Covaxin, on 100 healthy volunteers aged between 18 and 55 years. We will ensure that none of the volunteers have any comorbidities. AIIMS will conduct trials on 100 volunteers out of a total of 375 persons,” Professor of Community Medicine and Principal Investigator of COVID-19 vaccine trial, Sanjay Rai was quoted as saying by news agency IANS
.Balangir/Sambalpur: Uncounted cash to the tune of Rs 6.61 lakh was seized from two vehicles…
Ahmedabad: Prime Minister Narendra Modi cast his vote at a school in Ahmedabad during the…
Bhubaneswar: Rain and thunderstorm triggered by nor'wester may continue in several parts of Odisha, including…
Bhubaneswar: The Election Commission of India has issued notification for the 7th and last phase…
Bhubaneswar: The India Meteorological Department (IMD) on Tuesday sounded yellow and orange alerts of thunderstorm…
Bhubaneswar: The Biju Janata Dal (BJD) has appointed Nimapara MLA Samir Ranjan Dash as its…
Washington: Columbia University on Monday cancelled its university-wide graduation ceremony on May 15 following weeks…
Cuttack: In a rare order, the Orissa High Court has granted interim bail to the…